Sabra Health Care REIT, Inc.: insider trades · United States · SEC (Form 4)

About Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. is a healthcare-focused real estate investment trust and fits squarely within the Santé & Pharma sector classification. The company is incorporated in the United States, headquartered in Tustin, California, and its common stock, ticker SBRA, trades on the Nasdaq Stock Market LLC. Sabra was incorporated on May 10, 2010 as a wholly owned subsidiary of Sun Healthcare Group and began operations on November 15, 2010 following its separation from Sun. Over time, it has developed into a specialized healthcare REIT with a business model centered on owning and investing in real estate used for healthcare delivery.([s29.q4cdn.com](https://s29.q4cdn.com/533664328/files/doc_financials/2024/q4/SBRA-10K-2024-Final.pdf)) Sabra’s core portfolio is built around real estate serving the healthcare industry throughout the United States and Canada. Its principal asset categories include skilled nursing facilities, senior housing properties, and behavioral health facilities, with additional exposure to other specialized healthcare assets where risk-adjusted returns are compelling. This asset mix gives the company exposure to long-duration healthcare demand trends, especially aging demographics and the need for post-acute and senior care infrastructure, while also spreading tenant risk across multiple operating niches.([ir.sabrahealth.com](https://ir.sabrahealth.com/investors/overview/default.aspx)) From a competitive standpoint, Sabra operates in a sector where underwriting discipline, tenant quality, and rent coverage matter as much as asset location. The company positions itself as a leading healthcare REIT with deep industry experience and a broad North American footprint. In its recent disclosures, Sabra highlighted improving operating trends in managed senior housing, as well as new investments closed at attractive initial cash yields. These developments suggest a continued emphasis on selective capital deployment rather than aggressive expansion, which is generally consistent with the risk profile expected from a healthcare REIT.([ir.sabrahealth.com](https://ir.sabrahealth.com/investors/overview/default.aspx)) Recent news has focused on quarterly operating performance and capital allocation. In the second quarter of 2025, Sabra reported diluted FFO of $0.44 per share and updated its 2025 guidance, while also announcing new acquisitions, including a managed senior housing property and an additional post-quarter investment. The company continued its investor communications into 2026 with first-quarter materials and scheduled reporting events. For investors in French-speaking markets, SBRA is best viewed as a defensive real estate income vehicle with healthcare exposure, but one that remains sensitive to interest-rate conditions, operator credit quality, and healthcare regulation in its operating markets.([nasdaq.com](https://www.nasdaq.com/press-release/sabra-reports-second-quarter-2025-results-updates-2025-guidance-2025-08-04))